Article info
PDFEditorial commentary
Is it time to consider rationalising IFN-β treatment in individuals with multiple sclerosis?
- Correspondence to: G Giovannoni Department of Neuroinflammation, Institute of Neurology, University College London, Queen Square, London, WC1N 3BG, UK; G.Giovannoniion.ucl.ac.uk
Citation
Is it time to consider rationalising IFN-β treatment in individuals with multiple sclerosis?
Publication history
- First published August 16, 2004.
Online issue publication
August 16, 2004
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2004 Journal of Neurology Neurosurgery and Psychiatry